The largest database of trusted experimental protocols

105 protocols using 2480 wizard2

1

Measuring Adipocyte [18F]FDG Uptake

Check if the same lab product or an alternative is used in the 5 most similar protocols
Brown pre-adipocytes were seeded, grown to confluence and differentiated in 6-well plates as described in section General. Cell starving was performed for 1 h using unsupplemented, glucose-free DMEM. Thirty minutes prior to [18F]FDG incubation, cells were pre-treated with the adrenergic beta-3 agonist (2 μM CL 316,243), adrenergic beta antagonist (2 μM (S)-propranolol), the MCHR1 ligands (20 μM SNAP-7941 or FE@SNAP), or vehicle (baseline). [18F]FDG uptake was performed for 50 min at 37°C (humidified atmosphere, 5% CO2). Supernatant was taken off, cells were washed with ice-cold PBS and finally trypsinized. Radioactive cell fractions were gamma counted (2480 Wizard2, PerkinElmer) and normalized to percentage uptake per well. [18F]FDG uptake under baseline conditions refers to 100% uptake. Three independent experiments were performed in triplicates. Statistical analysis was performed using an unpaired, two-tailed t-test.
+ Open protocol
+ Expand
2

Radiolabeling Trastuzumab with 111In

Check if the same lab product or an alternative is used in the 5 most similar protocols
DTPA-trastuzumab-IRDye800CW was labeled with 2 MBq of 111In (Covidien, Petten, The Netherlands) per microgram of antibody in 0.5 M 2-(N-morpholino)ethanesulfonic acid (MES) buffer, pH 5.4 (2 times the volume of [111In]InCl3 solution) and incubated for 20 min at room temperature under metal free conditions. After incubation, unincorporated 111In was chelated by adding 50 mM ethylenediaminetetraacetic acid (EDTA) solution (to a final concentration of 5 mM).
Radiochemical purity was determined by instant thin-layer chromatography (ITLC) on silica gel strips (Agilent Technologies), using 0.15 M sodium citrate buffer, pH 6.0, as the mobile phase.
The immunoreactive fraction of dual-labeled trastuzumab was determined with BT474 cells as described by Lindmo et al. [18 (link)]. A serial dilution of BT474 cells was incubated with [111In]In-DTPA-trastuzumab-IRDye800CW for 1 h at room temperature. Subsequently, BT474 cells were centrifuged and analyzed in a gamma counter (2480 WIZARD2; PerkinElmer).
+ Open protocol
+ Expand
3

Biodistribution of 89Zr-Labeled MSCs in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
C57BL/6 mice were intravenously injected with 8 × 10589Zr‐labeled MSCs. Then, the mice were sacrificed at 2, 8, 24, 72, and 108 h p.i. Samples of major organs and tissues, including the brain, liver, heart, spleen, lung, kidney, stomach, muscle, tibia, femur, and knee were removed and weighed. To isolate the knee joint, an incision was made to reveal the femur, tibia, and knee ligaments. The knee was then carefully excised by transecting the ligamentous and musculotendinous attachments to the distal femur and proximal tibia. The radioactivity of each sample was measured using a γ‐counter (2480 WIZARD2; PerkinElmer, USA), and then the %ID/g per organ was calculated. The biodistribution of the other experimental groups was also evaluated after PET imaging.
Organuptake%ID/g=organcpm×standarddilutionrate×100/standardcpm×organweight
+ Open protocol
+ Expand
4

Quantification of 52Mn Biodistribution

Check if the same lab product or an alternative is used in the 5 most similar protocols
Quantification of 52Mn activity in each injected dose, in the urine, and in the feces were determined using a Capintec CRC-15PET dose calibrator. Injected dose activity was determined from the difference in activity recorded in the loaded syringe and injection line prior to and after injection. Quantification of 52Mn activity in ex vivo tissue samples was performed using a Perkin Elmer 2480 Wizard2 gamma counting system. Percentage injected (%ID) dose in ex vivo tissue samples was determined by comparing tissue counts to a measured aliquot of the injected dose. Bone, blood, fat, and muscle were estimated to account for 13%, 7%, 13%, and 40% of the total body weight. All measurements were corrected to account for decay. Limit of quantification (LOQ) was defined as 3 SD above the mean background counts per minute.
+ Open protocol
+ Expand
5

Arterial Input Function Measurement

Check if the same lab product or an alternative is used in the 5 most similar protocols
Arterial blood samples were collected manually at different time points (24 × 5 s, 1 × 60 s, 1 × 120 s, 1 × 300 s, 1 × 600 s, 2 × 1,200 s after injection) from the radial artery. Whole-blood radioactivity concentrations were measured using a γ-counter (2480 Wizard2 automatic γ-counter; PerkinElmer). To obtain the arterial input function (AIF), whole-blood samples were centrifuged to separate the plasma component, followed by the measurement of radioactivity in the plasma. The measured whole-blood and plasma tracer concentrations were used to calculate the time-dependent plasma–to–whole-blood ratios for each subject.
+ Open protocol
+ Expand
6

Biodistribution of Copper-64 Radiopharmaceuticals

Check if the same lab product or an alternative is used in the 5 most similar protocols
The PC-3 tumor bearing nude mice (n = 6/group) were injected with 7.4 MBq of 64Cu-Sar-PEG-VCN or 64Cu-Sar-RGD. At 48 h pi mice were euthanized and dissected. Blood, tumor, major organs, and tissues were collected and weighed wet. The radioactivity in the tissues was measured using a gamma counter (PerkinElmer 2480 WIZARD2). The results were presented as percentage injected dose per gram of tissue (%ID/g). For each mouse, the radioactivity of the tissue samples was calibrated with a known aliquot of the injected activity. Mean uptake (%ID/g) for a group of animals was calculated with standard deviations.
+ Open protocol
+ Expand
7

Zinc Uptake Assay in Hepa Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hepa cells were seeded in 24-well plates and incubated for 24 h with DMEM supplemented with 10% FBS in the absence or presence of 1000 μg/mL of P. ginseng extract. The Hepa cells were washed with wash buffer (10 mM HEPES pH 7.4, 142 mM NaCl, 10 mM glucose, 5 mM KCl) and then incubated with 0.5 μM ZnCl2 containing 1.87 nM 65ZnCl2 (18.5 kBq/well) in a zinc-deficient conditioned medium at 37°C for 20 min. Zinc uptake was stopped by adding an equal volume of ice-cold wash buffer containing 1 mM ethylenediaminetetraacetic acid (EDTA). After removing the buffer, the cells were washed two times with the same buffer and dissolved in 200 mM NaOH. Cell-associated radioactivity was measured with an automatic gamma counter (2480 Wizard2, Perkin Elmer, Waltham, MA), and protein concentration was determined using the BCA protein assay kit (Thermo Fisher Scientific, Waltham, MA). Zinc uptake rates were calculated and normalized to protein content.
+ Open protocol
+ Expand
8

Radiochemical Stability of [18F]21 and [177Lu]21

Check if the same lab product or an alternative is used in the 5 most similar protocols
[18F]21 or [177Lu]21 (50 μCi, 10 μL) was added to PBS (90 μL) or murine serum (90 μL) and the mixture was incubated at 37 °C for a certain time ([18F]21: 2 h, [177Lu]21: 8 d). The PBS mixture was injected directly into the radio-HPLC for analysis. The murine serum was precipitated with 0.1 mL of acetonitrile and centrifuged (10,000 rpm, 5 min). The supernatant was measured and analyzed by the radio-HPLC to determine the stability. For in vivo stability study, the radio tracers were injected into the tail vein of ICR mice and samples of blood were collected after a certain time post injection (pi) ([18F]21: 4 h, [177Lu]21: 9 h). The plasma proteins were precipitated using an equal volume of acetonitrile and centrifuged (10,000 rpm, 5 min). The RCP of radio tracer in supernatants were analyzed and quantified by radio-HPLC. The radio-HPLC method was as follows: A: 0.1% TFA in H2O, B: ACN, 0–10 min, 0–100% B. The flow rate was 1 mL/min, and the C18 column (4.6 × 150 mm, 5 μm, ZORBAX, Agilent) was used. When using HPLC to assess the stability of [177Lu]21, the effluent was collected every 30 s due to its less radioactivity, and samples were measured by an automatic γ-counter (2480 Wizard2, Perkin Elmer). The counted samples were plotted as intensity (cpm) against fraction [19 (link)].
+ Open protocol
+ Expand
9

In Vivo Tracking of Adoptive T Cell Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
The experimental setting is based on the tumor mouse model previously described 5 (link). Briefly, 1x107 ML2-B7 and ML2-B15 (control tumor) were inoculated s.c. into the right and left flank of NSG mice, respectively. 7 days after tumor inoculation mice were total body irradiated (TBI) with 1 Gy (Gulmay Irradiation Cabinet) to support the engraftment of the i.v. transferred TCR-transgenic TCM cells. At day 8 after tumor injection different numbers of TCR2.5D6 iRFP TCM or non-transduced TCM as control were injected i.v. in the tail vein. At the day of TCM transfer, mice were additionally injected i.p. with hIL-15 producing NSO cells (previously irradiated with 80 Gy). 3 days later, the radiotracer 89Zr-Df-aTCRmu-F(ab')2 was injected i.v. (2.13 ± 0.17MBq corresponding to 10-20 µg). PET/CT imaging was performed 48 h post 89Zr-Df-aTCRmu-F(ab')2 injection. At the day of imaging the mice were sacrificed, blood and organs were taken, weighed, and measured in the gamma-counter (2480 Wizard2, PerkinElmer) for biodistribution analysis. Tumor and organ uptake were expressed as percentage of injected dose per gram (%ID/g).
+ Open protocol
+ Expand
10

Evaluating Radioactive Antibody Binding Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
According to a previously
described flow cytometry protocol, cellular binding activity of Sn-mAbs
and 211At-mAbs was evaluated 6 days after 211At-labeling.29 (link)Using a previously
described in vitro binding assay with minor modifications,3 (link) we evaluated the binding activity of 211At-mAbs the day after labeling. In brief, serially diluted OE19 or
NUGC-3 cells in PBS containing 0.1% bovine serum albumin (BSA) and
2 mM ethylenediaminetetraacetic acid (EDTA) (BE-PBS) were incubated
for 30 min on ice with 5 kBq of 211At-mAbs. Then, samples
were washed three times with BE-PBS. The radioactivity bound to the
cells was counted using a gamma counter (2480 Wizard2;
PerkinElmer, Waltham, MA, USA), and the percentage of cellular binding
was calculated by dividing the radioactivity bound to the cells by
the initially added radioactivity. The immunoreactivity of 211At-mAbs was determined according to the method of Lindmo et al.34 (link)
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!